Chemoinformaics analysis of 7-Methyl-6-tridecene
| Molecular Weight | 196.378 | nRot | 9 |
| Heavy Atom Molecular Weight | 168.154 | nRig | 1 |
| Exact Molecular Weight | 196.219 | nRing | 0 |
| Solubility: LogS | -6.596 | nHRing | 0 |
| Solubility: LogP | 6.655 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 42 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 42.0502 |
| nHD | 0 | BPOL | 28.0898 |
| QED | 0.338 |
| Synth | 2.016 |
| Natural Product Likeliness | 1.675 |
| NR-PPAR-gamma | 0.014 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.043 |
| Pgp-sub | 0.001 |
| HIA | 0.004 |
| CACO-2 | -4.552 |
| MDCK | 0.0000119 |
| BBB | 0.666 |
| PPB | 0.988273 |
| VDSS | 3.581 |
| FU | 0.0151592 |
| CYP1A2-inh | 0.822 |
| CYP1A2-sub | 0.232 |
| CYP2c19-inh | 0.526 |
| CYP2c19-sub | 0.193 |
| CYP2c9-inh | 0.313 |
| CYP2c9-sub | 0.924 |
| CYP2d6-inh | 0.328 |
| CYP2d6-sub | 0.105 |
| CYP3a4-inh | 0.274 |
| CYP3a4-sub | 0.095 |
| CL | 4.756 |
| T12 | 0.202 |
| hERG | 0.021 |
| Ames | 0.002 |
| ROA | 0.012 |
| SkinSen | 0.943 |
| Carcinogencity | 0.028 |
| EI | 0.946 |
| Respiratory | 0.073 |
| NR-Aromatase | 0.019 |
| Antiviral | Yes |
| Prediction | 0.736327 |